Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1 , encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) gl...
Saved in:
Published in | Orphanet journal of rare diseases Vol. 17; no. 1; pp. 248 - 10 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
25.06.2022
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1750-1172 1750-1172 |
DOI | 10.1186/s13023-022-02398-3 |
Cover
Abstract | Background
Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in
GLUD1
, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults.
Results
Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (
p
= 0.002), and in peak hippocampal GluCEST values (
p
= 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10).
Conclusions
The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. |
---|---|
AbstractList | Abstract Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Results Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). Conclusions The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Results Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). Conclusions The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults.BACKGROUNDHyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults.Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10).RESULTSSubjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10).The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder.CONCLUSIONSThe high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Results Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry (p = 0.002), and in peak hippocampal GluCEST values (p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). Conclusions The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. Keywords: GLUD1, Hypoglycemia, Epilepsy, Glutamate, GluCEST Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1 , encoding glutamate dehydrogenase (GDH). Atypical absence seizures and neuropsychological disorders occur at high rates in this form of hyperinsulinism. Dysregulated central nervous system (CNS) glutamate balance, due to GDH overactivity in the brain, has been hypothesized to play a role. This study aimed to describe the neurologic phenotype in HI/HA syndrome and investigate CNS glutamate levels using glutamate weighted chemical exchange saturation transfer magnetic resonance imaging (GluCEST MRI). In this cross-sectional study, 12 subjects with HI/HA syndrome had plasma ammonia measurement, self- or parent-completed neurocognitive assessments, electroencephalogram (EEG), and GluCEST MRI at 7 T performed. GluCEST MRI measures were compared to a historic reference population of 10 healthy adults. Results Subjects were five males and seven females with median age of 25.5 years. Seventy-five percent of subjects reported a history of neurodevelopmental problems and 42% had neurocognitive assessment scores outside the normal range. Fifty percent had interictal EEG findings of generalized, irregular spike and wave discharges. Higher variability in hippocampal GluCEST asymmetry ( p = 0.002), and in peak hippocampal GluCEST values ( p = 0.008), was observed in HI/HA subjects (n = 9 with interpretable MRI) compared to the healthy reference population (n = 10). Conclusions The high prevalence of abnormal neurocognitive assessment scores and interictal EEG findings observed highlights the importance of longitudinal neuropsychological assessment for individuals with HI/HA syndrome. Our findings demonstrate the potential application of GluCEST to investigate persistent knowledge gaps in the mechanisms underlying the unique neurophenotype of this disorder. |
ArticleNumber | 248 |
Audience | Academic |
Author | De León, Diva D. Shinohara, Russell T. Nanga, Ravi Prakash Reddy Lucas, Alfredo Thomas, Nina H. Davis, Kathryn A. Reddy, Ravinder Rosenfeld, Elizabeth Thomas, Allison Roalf, David R. Revell, Andrew Y. |
Author_xml | – sequence: 1 givenname: Elizabeth orcidid: 0000-0002-1959-4457 surname: Rosenfeld fullname: Rosenfeld, Elizabeth email: rosenfelde@chop.edu organization: Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Congenital Hyperinsulinism Center, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania – sequence: 2 givenname: Ravi Prakash Reddy surname: Nanga fullname: Nanga, Ravi Prakash Reddy organization: Center for Advanced Metabolic Imaging in Precision Medicine, Hospital of the University of Pennsylvania – sequence: 3 givenname: Alfredo surname: Lucas fullname: Lucas, Alfredo organization: Penn Center for Neuroengineering and Therapeutics, University of Pennsylvania – sequence: 4 givenname: Andrew Y. surname: Revell fullname: Revell, Andrew Y. organization: Penn Center for Neuroengineering and Therapeutics, University of Pennsylvania – sequence: 5 givenname: Allison surname: Thomas fullname: Thomas, Allison organization: Behavioral Neuroscience Core, Center for Human Phenomic Science, Children’s Hospital of Philadelphia – sequence: 6 givenname: Nina H. surname: Thomas fullname: Thomas, Nina H. organization: Behavioral Neuroscience Core, Center for Human Phenomic Science, Children’s Hospital of Philadelphia, Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children’s Hospital of Philadelphia, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine – sequence: 7 givenname: David R. surname: Roalf fullname: Roalf, David R. organization: Department of Psychiatry, University of Pennsylvania Perelman School of Medicine – sequence: 8 givenname: Russell T. surname: Shinohara fullname: Shinohara, Russell T. organization: Penn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Center for Biomedical Image Computing and Analytics, Department of Radiology, University of Pennsylvania Perelman School of Medicine – sequence: 9 givenname: Ravinder surname: Reddy fullname: Reddy, Ravinder organization: Center for Advanced Metabolic Imaging in Precision Medicine, Hospital of the University of Pennsylvania – sequence: 10 givenname: Kathryn A. surname: Davis fullname: Davis, Kathryn A. organization: Penn Center for Neuroengineering and Therapeutics, University of Pennsylvania, Department of Neurology, University of Pennsylvania Perelman School of Medicine – sequence: 11 givenname: Diva D. orcidid: 0000-0003-1225-8087 surname: De León fullname: De León, Diva D. organization: Division of Endocrinology and Diabetes, Children’s Hospital of Philadelphia, Congenital Hyperinsulinism Center, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35752848$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktr3DAUhU1JaR7tH-iiDHTTLpxKlmXJm0IY-hgIFPqA7sS1LHs02NJUkkPTX98746TJhBKM8ZX0nSP56J5mR847k2UvKTmnVFbvImWkYDkpCnxZLXP2JDuhgpOcUlEc3auPs9MYN4SUnBH5LDtmXPBClvIk-7lcQwCdTLB_rOsXaW0WzkzBD763GobFdm2cT9dbs_DdfnWNdbAuToN1No7zGMYRzzZaWMRr1wY_mufZ0w6GaF7cfM-yHx8_fF9-zi-_fFotLy5zXZU05UxWwKVsGtFQXhcgOk3bktQSBOFd0_GSyEp0ggHTvOBEl3huWlMsS1IZzc6y1ezbetiobbAjhGvlwar9hA-9gpCsHowSrC7rpu00YBKtBtxRgK4aQRihkgv0ej97badmNK02LgUYDkwPV5xdq95fqbpgTFKCBm9uDIL_NZmY1GijNsMAzvgpqqLaURWva0RfP0A3fgoOo0KqppyWjNI7qgf8Aes6j_vqnam6EEQWUlTV7tzn_6HwafFKNF5MZ3H-QPD2QIBMMr9TD1OMavXt6yH76n4o_9K47SEE5Azo4GMMplPaJkjW7zKyg6JE7dpVze2qsF3Vvl0VQ2nxQHrr_qiIzaKIsOtNuEvuEdVf8Ab6fw |
CitedBy_id | crossref_primary_10_1097_MOP_0000000000001243 crossref_primary_10_1016_j_yebeh_2023_109181 crossref_primary_10_3389_fnagi_2024_1535158 crossref_primary_10_1016_j_bbr_2024_115399 crossref_primary_10_1155_2024_3961900 crossref_primary_10_1210_clinem_dgac604 crossref_primary_10_1016_j_ejphar_2023_175733 |
Cites_doi | 10.1007/s11064-013-1235-5 10.1016/j.nrl.2010.09.024 10.1126/scitranslmed.aaa7095 10.1126/science.1260419 10.1038/mp.2016.258 10.1210/jc.2012-2169 10.1002/mrm.27362 10.1007/s11064-016-1986-x 10.1016/j.jpeds.2004.10.040 10.1203/00006450-200109000-00010 10.1002/nbm.2949 10.1016/j.seizure.2008.01.005 10.1111/j.1469-8749.2008.03114.x 10.1016/j.neuroimage.2006.01.015 10.1523/JNEUROSCI.4413-09.2009 10.1016/0305-0491(93)90031-Y 10.1515/jpem-2016-0086 10.1530/EJE-09-0615 10.1016/j.pediatrneurol.2012.04.019 10.1056/NEJM199805073381904 10.1038/nm.2615 |
ContentType | Journal Article |
Copyright | The Author(s) 2022 corrected publication 2022 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: The Author(s) 2022 corrected publication 2022 – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13023-022-02398-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Science in Context ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1750-1172 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_73949bdfca004dcab157ac6b70301857 PMC9233810 A708287667 35752848 10_1186_s13023_022_02398_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: Pediatric Endocrine Society funderid: http://dx.doi.org/10.13039/100013845 – fundername: University of Pennsylvania Protocol Development Award – fundername: National Center for Advancing Translational Sciences grantid: UL1TR001878 funderid: http://dx.doi.org/10.13039/100006108 – fundername: National Institute of Mental Health grantid: R01MH119185 funderid: http://dx.doi.org/10.13039/100000025 – fundername: National Institute on Aging grantid: R56AG066656 funderid: http://dx.doi.org/10.13039/100000049 – fundername: National Institute of Neurological Disorders and Stroke grantid: R01NS116504; R01NS087516; T32NS091006 funderid: http://dx.doi.org/10.13039/100000065 – fundername: Children’s Hospital of Philadelphia Advancement of Hyperinsulinism Care and Research Frontier Program – fundername: National Institute of Biomedical Imaging and Bioengineering grantid: P41EB029460; P41EB015893 funderid: http://dx.doi.org/10.13039/100000070 – fundername: National Institute of Diabetes and Digestive and Kidney Diseases grantid: R01DK056268; T32DK063688 funderid: http://dx.doi.org/10.13039/100000062 – fundername: NINDS NIH HHS grantid: R01 NS087516 – fundername: NINDS NIH HHS grantid: R01 NS116504 – fundername: NIDDK NIH HHS grantid: R01 DK056268 – fundername: NIBIB NIH HHS grantid: P41 EB029460 – fundername: ; – fundername: ; grantid: R56AG066656 – fundername: ; grantid: R01NS116504; R01NS087516; T32NS091006 – fundername: ; grantid: R01MH119185 – fundername: ; grantid: R01DK056268; T32DK063688 – fundername: ; grantid: P41EB029460; P41EB015893 – fundername: ; grantid: UL1TR001878 |
GroupedDBID | --- 0R~ 123 29N 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BNQBC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ISR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW ~8M AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c641t-386a588bb7b1592a7fc1d4098a705fbf540867f73a3c5250c4284191250406ec3 |
IEDL.DBID | M48 |
ISSN | 1750-1172 |
IngestDate | Wed Aug 27 01:15:49 EDT 2025 Thu Aug 21 18:31:32 EDT 2025 Thu Sep 04 23:53:15 EDT 2025 Fri Jul 25 03:19:02 EDT 2025 Tue Jun 17 21:54:43 EDT 2025 Tue Jun 10 20:08:39 EDT 2025 Fri Jun 27 03:46:58 EDT 2025 Mon Jul 21 05:59:37 EDT 2025 Tue Jul 01 02:23:30 EDT 2025 Thu Apr 24 22:53:10 EDT 2025 Sat Sep 06 07:29:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | GLUD1 Hypoglycemia Glutamate GluCEST Epilepsy |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c641t-386a588bb7b1592a7fc1d4098a705fbf540867f73a3c5250c4284191250406ec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1225-8087 0000-0002-1959-4457 |
OpenAccessLink | https://doi.org/10.1186/s13023-022-02398-3 |
PMID | 35752848 |
PQID | 2691514311 |
PQPubID | 76088 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_73949bdfca004dcab157ac6b70301857 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9233810 proquest_miscellaneous_2681036599 proquest_journals_2691514311 gale_infotracmisc_A708287667 gale_infotracacademiconefile_A708287667 gale_incontextgauss_ISR_A708287667 pubmed_primary_35752848 crossref_citationtrail_10_1186_s13023_022_02398_3 crossref_primary_10_1186_s13023_022_02398_3 springer_journals_10_1186_s13023_022_02398_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-06-25 |
PublicationDateYYYYMMDD | 2022-06-25 |
PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Orphanet journal of rare diseases |
PublicationTitleAbbrev | Orphanet J Rare Dis |
PublicationTitleAlternate | Orphanet J Rare Dis |
PublicationYear | 2022 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | M Uhlen (2398_CR28) 2015; 347 C Spanaki (2398_CR26) 2014; 39 KE Snider (2398_CR1) 2013; 98 CA Stanley (2398_CR2) 1998; 338 TM Achenbach (2398_CR14) 2009 RM Roth (2398_CR16) 2005 PA Yushkevich (2398_CR17) 2006; 31 2398_CR27 DM Raizen (2398_CR6) 2005; 146 C Spanaki (2398_CR4) 2017; 42 K Nakano (2398_CR21) 2012; 47 RPR Nanga (2398_CR12) 2018; 80 X Bao (2398_CR23) 2009; 29 RR Kapoor (2398_CR18) 2009; 161 KA Davis (2398_CR10) 2015; 7 N Bahi-Buisson (2398_CR20) 2008; 17 D Ninkovic (2398_CR25) 2016; 29 K Cai (2398_CR9) 2013; 26 F Perez Errazquin (2398_CR22) 2011; 26 C Su (2398_CR8) 2018; 2018 DR Roalf (2398_CR11) 2017; 22 RC Hudson (2398_CR3) 1993; 106 GA Gioia (2398_CR15) 2015 P De Lonlay (2398_CR19) 2001; 50 K Cai (2398_CR24) 2012; 18 N Bahi-Buisson (2398_CR5) 2008; 50 C MacMullen (2398_CR7) 2001; 86 P Harrison (2398_CR13) 2015 35982497 - Orphanet J Rare Dis. 2022 Aug 18;17(1):315. doi: 10.1186/s13023-022-02466-8 |
References_xml | – volume: 39 start-page: 500 issue: 3 year: 2014 ident: 2398_CR26 publication-title: Neurochem Res doi: 10.1007/s11064-013-1235-5 – volume: 86 start-page: 1782 issue: 4 year: 2001 ident: 2398_CR7 publication-title: J Clin Endocrinol Metab – volume: 26 start-page: 248 issue: 4 year: 2011 ident: 2398_CR22 publication-title: Neurologia doi: 10.1016/j.nrl.2010.09.024 – volume: 7 start-page: 309ra161 issue: 309 year: 2015 ident: 2398_CR10 publication-title: Sci Transl Med. doi: 10.1126/scitranslmed.aaa7095 – volume: 347 start-page: 1260419 issue: 6220 year: 2015 ident: 2398_CR28 publication-title: Science doi: 10.1126/science.1260419 – ident: 2398_CR27 – volume: 22 start-page: 1298 issue: 9 year: 2017 ident: 2398_CR11 publication-title: Mol Psychiatry doi: 10.1038/mp.2016.258 – volume: 98 start-page: E355 issue: 2 year: 2013 ident: 2398_CR1 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-2169 – volume-title: The Achenbach system of empirically based assessment (ASEBA): development, findings, theory, and applications year: 2009 ident: 2398_CR14 – volume: 80 start-page: 2033 issue: 5 year: 2018 ident: 2398_CR12 publication-title: Magn Reson Med doi: 10.1002/mrm.27362 – volume-title: Behavior rating inventory of executive function-second edition (BRIEF2) year: 2015 ident: 2398_CR15 – volume: 42 start-page: 92 issue: 1 year: 2017 ident: 2398_CR4 publication-title: Neurochem Res doi: 10.1007/s11064-016-1986-x – volume: 146 start-page: 388 issue: 3 year: 2005 ident: 2398_CR6 publication-title: J Pediatr doi: 10.1016/j.jpeds.2004.10.040 – volume: 50 start-page: 353 issue: 3 year: 2001 ident: 2398_CR19 publication-title: Pediatr Res doi: 10.1203/00006450-200109000-00010 – volume: 26 start-page: 1278 issue: 10 year: 2013 ident: 2398_CR9 publication-title: NMR Biomed doi: 10.1002/nbm.2949 – volume: 17 start-page: 658 issue: 7 year: 2008 ident: 2398_CR20 publication-title: Seizure doi: 10.1016/j.seizure.2008.01.005 – volume: 50 start-page: 945 issue: 12 year: 2008 ident: 2398_CR5 publication-title: Dev Med Child Neurol doi: 10.1111/j.1469-8749.2008.03114.x – volume: 31 start-page: 1116 issue: 3 year: 2006 ident: 2398_CR17 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2006.01.015 – volume: 29 start-page: 13929 issue: 44 year: 2009 ident: 2398_CR23 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4413-09.2009 – volume: 106 start-page: 767 issue: 4 year: 1993 ident: 2398_CR3 publication-title: Comp Biochem Physiol B doi: 10.1016/0305-0491(93)90031-Y – volume: 29 start-page: 1083 issue: 9 year: 2016 ident: 2398_CR25 publication-title: J Pediatr Endocrinol Metab doi: 10.1515/jpem-2016-0086 – volume: 161 start-page: 731 issue: 5 year: 2009 ident: 2398_CR18 publication-title: Eur J Endocrinol doi: 10.1530/EJE-09-0615 – volume: 47 start-page: 119 issue: 2 year: 2012 ident: 2398_CR21 publication-title: Pediatr Neurol doi: 10.1016/j.pediatrneurol.2012.04.019 – volume-title: Behavior rating inventory of executive function-adult version (BRIEF-A) year: 2005 ident: 2398_CR16 – volume: 338 start-page: 1352 issue: 19 year: 1998 ident: 2398_CR2 publication-title: N Engl J Med doi: 10.1056/NEJM199805073381904 – volume-title: Adaptive behavior assessment system, third edition (ABAS-3) year: 2015 ident: 2398_CR13 – volume: 2018 start-page: 2802540 year: 2018 ident: 2398_CR8 publication-title: J Diabetes Res – volume: 18 start-page: 302 issue: 2 year: 2012 ident: 2398_CR24 publication-title: Nat Med doi: 10.1038/nm.2615 – reference: 35982497 - Orphanet J Rare Dis. 2022 Aug 18;17(1):315. doi: 10.1186/s13023-022-02466-8 |
SSID | ssj0045308 |
Score | 2.3967266 |
Snippet | Background
Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in
GLUD1
, encoding glutamate dehydrogenase (GDH). Atypical... Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence seizures... Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH). Atypical absence... Abstract Background Hyperinsulinism hyperammonemia (HI/HA) syndrome is caused by activating mutations in GLUD1, encoding glutamate dehydrogenase (GDH).... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 248 |
SubjectTerms | Age Ammonia Attention deficit hyperactivity disorder Central nervous system Cognition Convulsions & seizures Cross-Sectional Studies Development and progression Diagnosis EEG Electroencephalography Epilepsy Executive function Female Firing pattern GluCEST Glucose GLUD1 Glutamate Glutamate dehydrogenase Glutamate Dehydrogenase - genetics Glutamates Hippocampus Human Genetics Humans Hyperammonemia Hyperammonemia - genetics Hyperinsulinism - genetics Hypoglycemia Magnetic resonance imaging Male Medical research Medicine Medicine & Public Health Methods Mutation Neuroimaging Participation Pharmacology/Toxicology Phenotype Phenotypes Plasma Rare diseases Rare endocrinological diseases Seizures |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojwDpQoIiQNYjeP4kWOpqApSOQCV9mY5k5iu1GYR2T2UX8-M82hTVHrhuOvJbjIzHn-TGX9m7A00UNogS66l17ywteC2AOBaVxAaZQXE7WPHX_TRSfF5oRZXjvqinrCeHrhX3J6RZVFWdQCP5qzBV0IZD7oiTyUeI4q-WZmNyVQfgwslMztukbF6r6PyHNUrc06bOS2Xs2UosvX_HZOvLErXGyavVU3jYnT4gN0fUGS639_9NrvTtA_Z3eOhTv6ILQ4mHubf-AMporw0MlcOkS6lzq4VvX5NVyGOnl4Q5XHfmL7szvvPnpy0OV_6dCQ2eMxODj9-PzjiwxkKHHQh1lxa7ZW1VWVQcWXuTQBRY05nvclUqAICNqtNMNJLoAonYDpSYA5HzGaZbkA-YVst_tUzlmbWK5_XmGHJrGgQlEtjDFg6gbIOUkHCxKhSBwPBOJ1zceZiomG1683g0AwumsHJhL2brvnZ02v8U_oDWWqSJGrs-AU6jBscxt3mMAl7TXZ2RH7RUnfND7_pOvfp21e3byL_v9Yo9HYQCit8BvDDZgXUBPFlzSR3ZpI4O2E-PLqTG6JD53JdCgKqQiTs1TRMV1LHW9usNiRjBaILVZYJe9p73_TcEjE2mskmzMz8cqaY-Ui7PI3c4YjnidMtYe9HD768rZsV__x_KP4Fu5fHGah5rnbY1vrXpnmJiG5d7cbJ-weAIkSN priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDI9gSIgXxPcKAxWExANEa5o2SZ_QmJgG0ngAJt1blLrNdhK7jvXuAf567DTt6BB7vIt7V8eOY8fOz4y9hhYq42XFlXSKF6YR3BQAXKkafFsaAeH62NEXdXhcfF6Ui3jg1seyytEmBkPddEBn5Lu5qgRt7kK8P__JqWsUZVdjC42b7JZAT4RaN-jFFHAVpczMeFHGqN2eknSUtcw5Xek0XM42o4DZ_69l_mtrulo2eSV3Grakg3vsbvQl071B-PfZjXb1gN0-itnyh2yxP6Ex_8YfSNHXSwN-ZbR3KdV3dXQIm3Y-jJ7-IuDjoTx92Z8Nnx3x3p4tXTrCGzxixwcfv-8f8thJgYMqxJpLo1xpTF3rGt2X3GkPosHIzjidlb726LYZpb2WTgLlOQGDkgIjOcI3y1QL8jHbWuFfbbM0M650eYNxlsyKFl1zqbUGQ30oGy9LSJgYp9RChBmnbhc_bAg3jLKDGCyKwQYxWJmwt9Mz5wPIxrXUH0hSEyUBZIcvuosTG9eb1bIqqrrx4FAPGnDIt3agajJwBH-VsFckZ0sQGCuqsTlxm763n759tXs6dAFQConeRCLfIQ_g4pUFnAlCzZpR7swocY3CfHhUJxttRG8vNTphL6dhepLq3lZttyEaI9DHKKsqYU8G7Zv4luhpo5hMwvRML2cTMx9ZLU8Dgjh69YTslrB3owZfvtb_J_7p9Vw8Y3fysLYUz8sdtrW-2LTP0WNb1y_CsvwDrho79Q priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB7BIiEuiDeBBQWExAEs4jh-5LhUrBak5QCs1JvlODFbiU0RaQ_w65lxnLJZHhLHxuM29oztbzoznwGe-c7XJoiaKeEUq0zLmam8Z0o1PnTScB_Lx47fq6OT6t1SLhNNDtXCnI_fc6NeDRRYo0hjyagM0zBxGa5IfEjWvFCLadetpCjMVBTzx36zgyfy8_--C587hi6mSF6Ik8bj5_AGXE-4MT8YFX0TLnX9Lbh6nCLjt2G52DEv_8AvyBHX5ZGrMu1tOeVyrekP13wdYuvpdyI5HlPRV8PZ-NmRWXZnK5dPVAZ34OTwzafFEUu3JjCvKr5hwignjWka3SBUKZ0OnrfoxRmnCxmagBDNKB20cMJTTNOjA1Kh10ZcZoXqvLgLez3-1H3IC-OkK1v0qURRdQjDhdbaG7pzsg1C-gz4NKXWJ0pxutnii42uhVF2VINFNdioBisyeLHr83Uk1Pin9GvS1E6SyLDjA7QRm9aW1aKu6qYN3qEdtN7huLXzqqHNjKiuMnhKerZEd9FTPs1ntx0G-_bjB3ugI-O_Uij0PAmFNY7Bu1SegDNBDFkzyf2ZJK5HP2-ezMmm_WCwpao5QVPOM3iya6aelOPWd-styRiOeELWdQb3RuvbjVsgqkY1mQz0zC5nEzNv6VenkS0cETyxuGXwcrLgX6_194l_8H_iD-FaGdeaYqXch73Nt233CNHapnkcl-lPD5M01g priority: 102 providerName: Springer Nature |
Title | Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome |
URI | https://link.springer.com/article/10.1186/s13023-022-02398-3 https://www.ncbi.nlm.nih.gov/pubmed/35752848 https://www.proquest.com/docview/2691514311 https://www.proquest.com/docview/2681036599 https://pubmed.ncbi.nlm.nih.gov/PMC9233810 https://doaj.org/article/73949bdfca004dcab157ac6b70301857 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_tQ0K8IL7JGFVASDyAoYkT23lAqKs2jUqb0EalvlmOk2yVtpQ1rcT467lzPiBjIPFUNb6kte_Od5c7_w7gtc1togqeMMGNYJHKAqYia5kQqS3yWAXWHR87OhaH02gyi2cb0LY7ahawujW0o35S0-XF--9X159Q4T86hVfiQ0XJN8pGhoyOairGN2Hb5YuolC_qsgpRzF2HOrSYQxag5W4P0dz6jJ6hcnj-f-7av5mtmyWVN_Kqzlwd3Id7jZ_pj2rBeAAbefkQ7hw1mfRHMBt3SM0_8AE--oG-w7Zs9kKfar8W9ILWXxRu9PyaQJHr0vV5dVl_NyTG-eXc-C30wWOYHux_HR-ypssCsyIKVowrYWKl0lSm6NqERhY2yDDqU0YO4yIt0KVTQhaSG24pB2oxYIkwyiPss6HILX8CWyX-1DPwh8rEJswwBuPDKEe3nUspraIelVnBY-tB0C6ptg0EOXXCuNAuFFFC12zQyAbt2KC5B2-7e77VABz_pN4jTnWUBJ7tLiyWZ7rRRS15EiVpVliDMpFZg_OWxoqUNj-CxvLgFfFZEzxGSfU3Z2ZdVfrz6YkeSdchQAgketMQFQucgzXNcQZcCULU6lHu9ihRf21_uBUn3Yq_DkUSkCsbBB687IbpTqqJK_PFmmhUgP5HnCQePK2lr5s3Ry8c2aQ8kD257C1Mf6Scnzt0cfT4CfXNg3etBP_6W39f-J3_YtNzuBs6VRMsjHdha7Vc5y_QuVulA9iUMzmA7dFocjrBz7394y8neHUsxgP3wmTgdPonD0tKow |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8EBgQE4gGiNXFiOw8T2samla0VGpvUN-M4yVaJNWNphcYfx9_GneN0ZIi97bH1Ja195_vwnX8H8MYUJpUlSwPONA9imYeBjI0JOM9MWSQyNPb62HDEdw7jz-NkvAS_27swVFbZ6kSrqPPK0Bn5asTTkIx7GH48_RFQ1yjKrrYtNLRrrZCvWYgxd7Fjtzj_iSFcvTb4hPx-G0XbWwebO4HrMhAYHoezgEmuEymzTGRo2iMtShPmGPVILfpJmZXo0kguSsE0M5QDNOiwxxjlEPZXnxeG4XtvwHJMByg9WN7YGn3Zb21BnLC-bK_qSL5aU5qQ8qZRQJdKZcA65tB2DfjXNvxlHC8Xbl7K3lqjuH0X7jhv1l9vxO8eLBXT-3Bz6PL1D2C8ucCD_oUv8NHb9C2CptO4PlWYVXQM7FelHT0-J-jlpkB-Up80nzWtfnEy0X4LsPAQDq9llR9Bb4o_9QT8vtSJjnKM9Fg_LjA4YEIII6kTZl6yxHgQtkuqjAM6p34b35UNeCRXDRsUskFZNijmwfvFM6cNzMeV1BvEqQUlQXTbL6qzI-V2vBIsjdMsL41GOciNxnkLbXhGKpYAuDx4TXxWBMIxpSqfIz2vazX4uq_Whe1DwDkSvXNEZYVzMNpdmsCVINyuDuVKhxK1hOkOt-KknJaq1cWe8uDVYpiepMq7aVHNiUaG6OUkaerB40b6FvNm6Osjm6QHoiOXnYXpjkwnxxbDHOMKwpbz4EMrwRd_6_8L__TqWbyEWzsHwz21NxjtPoPbkd1nPIiSFejNzubFc_QfZ9kLt0l9-HbdeuEPqzB89Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED_BJk28IL4XGBAQEg8QLYkT23ksg2orbEKMSX2zHCfeKrFkWtsH-Ou5c5ywjA-Jx8bntPZ9-K539zPAK1ObQlpWRJxpHmWySiKZGRNxXhpb5zIxrn3s8Ijvn2SzeT6_0sXvqt37lGTX00AoTc1q96KynYpLvrukdBvlH9OImjNlxG7CpsyLAsOvzclkdjzrrXGWs1j2zTJ_nDk6kBxu_-_W-crxdL108lr-1B1L0ztw2_uT4aQTgLtwo27uwdahz5jfh_negMj8A18Qor8XOgxLb_NCqvFq6Y_YsLVu9Ow7gR93JeqL5Xn3WZO41ucLHfYQBw_gZPrh695-5G9TiAzPklXEJNe5lGUpSnRhUi2sSSqM7qQWcW5Li66b5MIKppmhXKfBwCTDaI4wzmJeG_YQNhr8qm0IY6lznVYYa7E4q9E9Z0III-kuysqy3ASQ9FuqjIcapxsvvikXckiuOjYoZINybFAsgDfDnIsOaOOf1O-IUwMlgWS7B-3lqfI6pwQrsqKsrNEoB5XRuG6hDS_JyBEEVgAvic-KYDAaqrM51evlUh0cf1ET4W4C4ByJXnsi2-IajPZtC7gThJw1otwZUaKemvFwL07K24mlSnmRkMuaJAG8GIZpJtW-NXW7JhqZoJ-B0h3Ao076hnUz9LaRTTIAMZLL0caMR5rFmUMRR8-e0N0CeNtL8K-f9feNf_x_5M9h6_P7qfp0cPTxCdxKndrxKM13YGN1ua6fokO3Kp95nf0JealBgw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterizing+the+neurological+phenotype+of+the+hyperinsulinism+hyperammonemia+syndrome&rft.jtitle=Orphanet+journal+of+rare+diseases&rft.au=Rosenfeld%2C+Elizabeth&rft.au=Nanga%2C+Ravi+Prakash+Reddy&rft.au=Lucas%2C+Alfredo&rft.au=Revell%2C+Andrew+Y.&rft.date=2022-06-25&rft.issn=1750-1172&rft.eissn=1750-1172&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13023-022-02398-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13023_022_02398_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1750-1172&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1750-1172&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1750-1172&client=summon |